Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244226 · ClinicalTrials.gov registry record · Phase 2
Pediatric Pain Optimization After Tonsillectomy
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT05244226: Completed Phase 2 study, sponsored by Duke University.
NCT05244226 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 66 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05244226, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery.
Primary Outcome
Postoperative opioid medication expressed in oral morphine equivalents (OME) per kilogram
Interventions
- DRUG Methadone
- DRUG Fentanyl/Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2022-04-08 |
| Est. Completion | 2023-05-10 |
| Phase | Phase 2 |
What the finished NCT05244226 record still lists
NCT05244226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT05244226 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05244226 about?
NCT05244226 is a clinical study titled "Pediatric Pain Optimization After Tonsillectomy". The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery.
What is the current status of trial NCT05244226?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2022-04-08. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT05244226?
The interventions under investigation include: Methadone (DRUG), Fentanyl/Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT05244226?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05244226's enrollment target sits among peer trials
66 975th of 2000 higher than 1,014 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI